Furthermore, rutaecarpine improves imiquimod-induced psoriasis-like dermatitis by modulating the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and toll-like receptor 7 signaling25. Here, NFKB1 is linked to skin disorder.